First Report Customer Care 
All time: 4.6

Latest / Last 30 Days: 5.0

521 Reviews

Credit Rating - PHARMEXX UK HOLDINGS LIMITED

ANALYSIS
Credit Risk Update: ACCOUNTS DUE FLAG: PHARMEXX UK HOLDINGS LIMITED, Ashfield House, Resolution Road, Ashby-De-La-Zouch, Leicestershire, LE65 1HW. The legal status is a Private Limited Company and the current status at the registry of companies is Active. The last filed accounts are dated 30 September 2020. The company was incorporated on 27 October 2006.

The accounts next due date is 30 June 2022. There are no mortgages.

The above was based on public record information as at 20 April 2024 and may not reflect the current status. Please access the current report to ascertain the current status and credit rating.
SUMMARY
Registered Number: 05980202
Date Incorporated: 27 October 2006
Date Latest Accounts: 30 September 2020
BUSINESS INFORMATION
Legal Form: Private Limited Company
Previous Names: PHARMEXX UK LIMITED, PHARMEXX INTERNATIONAL LIMITED
Registered Number: 05980202
Annual Return: 27 October 2015
Registered Office: Ashfield House, Resolution Road, Ashby-De-La-Zouch, Leicestershire, LE65 1HW
SIC Code and Operations: 64209
SECURED CREDITORS
Number of Mortgages 0
Satisfied Mortgages 0
Part Satisfied Mortgages 0
Unsatisfied Mortgages 0
CREDIT RISK RATING
This is the credit risk assessment used by one of the top UK credit reference agencies.
Risk Score (1-100):

PHARMEXX UK HOLDINGS LIMITED

Click Here

to view this information

Risk Assessment:
Credit Rating:



First Report Score: (0-10):

Financial Status Guide:
10  trafficlight Very Strong
9   Strong
8 Very Good
7 Good
6 Above Average
5 Average
4 Below Average
3 Poor
2 Weak
1 Very Weak
0 Critical
Report Created On 30 April 2024 Copyright © 2024 First Report Ltd


Recent Searches

Reg No. Reg Name Status
02456441 PHARMEXX UK LIMITED Active
08775714 PHARMEXXX LAB LIMITED Active - Proposal to Strike off
13718540 PHARMEZ LTD Active
12688158 PHARMEZE LTD Active
14838241 PHARMEZY LTD Active

In using this service you agree to the Terms and Conditions

© 2024 First Report Ltd